Open AccessPromoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers
Author(s) -
Jichang Han,
Feng Xu,
Na Chen,
Guanbin Qi,
YuJu Wei,
Hongbing Li,
Yijie Zhang,
Jinghe Li,
Xiuli Wang,
Wen Xu,
Xiaofeng Li,
Lijun Jin,
Jiaoyuan Jia,
Zhong-Sen Ma
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.154926
Subject(s) - methylation , lung cancer , meta analysis , inclusion and exclusion criteria , oncology , adenocarcinoma , medicine , lung , cancer research , dna methylation , cancer , biology , pathology , gene , gene expression , biochemistry , alternative medicine
Objection: The aim of this study is to investigate the association between promoter methylation of RASSF1A and p16 and the clinicopathological features in lung cancers.